Finance

Lists
Why is WINT up 50,00%?
Dive Deeper
WINT:OTCMKTS
Windtree Therapeutics Inc
0,00030 USD
+50,00%
(+0,00010) 1D
17-ноя., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WINT...
Open
0,00 USD
High
0,00 USD
Low
0,00 USD
Mkt. cap
10,11 миң
Avg. vol.
9,94 миң
Volume
342,00
52-wk high
0,06 USD
52-wk low
0,00 USD
Beta
1,70
Shares outstanding
33,71 млн
No. of employees
14
Open
0,00 USD
High
0,00 USD
Low
0,00 USD
Mkt. cap
10,11 миң
Avg. vol.
9,94 миң
Volume
342,00
52-wk high
0,06 USD
52-wk low
0,00 USD
Beta
1,70
Shares outstanding
33,71 млн
No. of employees
14
News stories
From web sources and news partners
Profile
Windtree Therapeutics, Inc. is an American company which was set up in 1992 and now is based in Warrington, Pennsylvania, developing drug products for patients with respiratory disease. The company joined an alliance with Laboratorios del Dr. Esteve, S.A. In 2016, Discovery Laboratories changed name to Windtree Therapeutics, Inc. Wikipedia
About Windtree Therapeutics Inc
CEO-
Employees14
Founded1992-ж., 6-ноя.
HeadquartersУоррингтон Тауншип, Пенсильвания, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2024-ж. дек.
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,19 млн
2,27 млн
2,18 млн
1,90 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,73 млн
1,82 млн
1,80 млн
1,86 млн
Operating expense
3,92 млн
4,09 млн
3,98 млн
3,75 млн
Total operating expenses
3,92 млн
4,09 млн
3,98 млн
3,75 млн
Operating income
-3,92 млн
-4,09 млн
-3,98 млн
-3,75 млн
Other non operating income
8,64 млн
-20,00 миң
873,00 миң
2,70 млн
EBT including unusual items
2,69 млн
-4,04 млн
-10,63 млн
-31,52 млн
EBT excluding unusual items
4,46 млн
-4,02 млн
-10,70 млн
-15,39 млн
Income tax expense
-77,00 миң
-
-
-3,43 млн
Effective tax rate
-2,86%
-
-
10,89%
Other operating expenses
-
-
-
-
Net income
2,77 млн
-4,04 млн
-10,63 млн
-28,08 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
8,00 миң
7,00 миң
198,00 миң
758,00 миң
Interest expense
-61,00 миң
-20,00 миң
-7,39 млн
-15,29 млн
Net interest expenses
-53,00 миң
-13,00 миң
-7,19 млн
-14,54 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,90 млн
-4,07 млн
-3,97 млн
-3,39 млн
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору